Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Accelerating mortgage savings is key for aspiring homeowners. Explore various methods to enhance your savings journey.
15,117 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Solana sits at a pivotal juncture in 2026, with traders weighing a rising wedge against thinning volume and a stubbor...
Intel and AMD delivered contrasting Q4 results, highlighting divergent paths: Intel grappling with foundry losses ami...
Scotiabank boosted Cameco's price target to $175 as a global push for nuclear power gains traction and a new supply d...
This article dives into EverCommerce (evcm) 2026 earnings, unpacking Q1 results, growth drivers, and the implications...
Chewy has faced a rough year, with shares falling and growth challenges ahead. Yet, a closer look under the hood show...
Bitcoin holds near a critical level as CME's volatility futures near launch, stoking bets on a push toward the mid-80...
This article dives into exagen (XGN) 2026 earnings, unpacking Q1 results, business momentum, and the path to full-yea...
Investors are watching the CLARITY Act as the Senate considers the bill this week. Traders say crypto markets massive...
Investors have seen Broadcom swing from a rough start to a strong rally. This guide breaks down whether today is the ...
Betterware de Mexico appears to be trading at a discount despite a growth plan centered on Latin America expansion an...
In a hypothetical SpaceX IPO in 2026, Meta’s Mark Zuckerberg could emerge as the biggest winner, driven by AI investm...